Plaque Stratification Using Ccta in Coronary ARtery Disease (PoSTCARD)
NCT ID: NCT04439643
Last Updated: 2023-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
800 participants
OBSERVATIONAL
2020-02-05
2022-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Elucidate Vasodilatory Capacity From Histology-Defined Analysis of Coronary CT Angiography
NCT05524896
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
NCT01943903
New Technologies to Determine Carotid Plaque Vulnerability
NCT02224339
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With (N)STEMI or Unstable Angina
NCT05600088
ELUCIDATE FFRct Study
NCT06018194
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Development / training
Selected by stratified partitioning
vascuCAP
time to event and phenotype classification model
Sequestered / test
Selected by stratified partitioning
vascuCAP
time to event and phenotype classification model
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vascuCAP
time to event and phenotype classification model
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject must have been ≥ 18 years of age at the time of the CCTA
Exclusion Criteria
* CCTA taken less than 3 months after deployment of new scanner
* Subject with insufficient CCTA image quality
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of South Carolina
OTHER
Elucid Bioimaging Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew J. Buckler, MS
Role: PRINCIPAL_INVESTIGATOR
Elucid Bioimaging Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of South Carolina
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PoSTCARD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.